eurofeedback in children with attention deficit hyperactivity disorder (ADHD)

Not Applicable

Completed

Conditions: Attention deficit hyperactivity disorder (ADHD)
Mental and Behavioural Disorders
Hyperkinetic disorders

Registration Number: ISRCTN76187185

Lead Sponsor: Ruhr-Universität Bochum (Germany)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 144

Inclusion Criteria

Subjects meeting all of the following criteria will be considered for admission to the trial:
1. Both males and females, aged 7 to less than 10 years inclusive
2. Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) diagnosis of ADHD, combined type
3. Ability of subject to understand character and individual consequences of clinical trial
4. Written informed consent must be available before enrolment in the trial
5. For women with childbearing potential, adequate contraception

Exclusion Criteria

1. Below IQ 80 (Culture Fair Test [CFT])
2. Bipolar disorder, psychosis, serious obsessive compulsive disorder (OCD), chronic serious tics or Tourette syndrome
3. Pharmacotherapy for severe anxiety and mood disorders and psychosis
4. Major neurological or medical illness
5. Non-German speaking child and primary caretaker
6. No telephone
7. Suicidal
8. Pregnancy and lactation
9. Participation in other clinical trials and observation period of competing trials, respectively

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in ADHD Rating Scale at pre-test, treatment phase, post-test 1, post-test 2, follow-up.

Secondary Outcome Measures

Name	Time	Method
The following will be assessed at pre-test, post-test 1, post-test 2, follow-up: <br>1. Clinical Global Impressions - Severity (CGI-S) Scale (at pre-test) and Clinical Global Impressions - Improvement (CGI-I) Scale (at post-test 1, post-test 2, follow-up)<br>2. Resumption of medication by choice of family during follow-up (yes/no) <br>3. Change in neuropsychological and neurophysiological parameters